Management of 7-Year-Old with Bronchopneumonia, Elevated Bilirubin, and Low CRP
Start empiric antibiotic therapy immediately with oral amoxicillin 90 mg/kg/day divided in 2 doses (maximum 4 g/day), and investigate the elevated bilirubin (79 µmol/L) as a separate issue while treating the pneumonia. 1
Pneumonia Management
Antibiotic Selection
For a 7-year-old with bronchopneumonia, the IDSA/PIDS guidelines clearly recommend:
- Primary therapy: Amoxicillin 90 mg/kg/day in 2 divided doses (maximum 4 g/day) 1
- If atypical pneumonia cannot be excluded: Add a macrolide (azithromycin 10 mg/kg day 1, then 5 mg/kg days 2-5, maximum 500 mg/250 mg) 1
The CRP of 5.3 mg/L is notably low for bacterial pneumonia. Research shows that bacterial respiratory infections typically produce CRP >40 mg/L in 35% of cases, while viral infections rarely exceed this threshold 2. However, low CRP does not rule out bacterial infection - only 55% of confirmed bacterial infections had CRP >40 mg/L 2. Given the clinical diagnosis of bronchopneumonia requiring admission, empiric antibiotics are warranted regardless of the low CRP.
Monitoring Response
- Expect clinical improvement within 48-72 hours of starting antibiotics 1
- If no improvement or deterioration occurs, perform:
- Clinical reassessment of severity
- Imaging to assess progression
- Further investigation for resistant organisms or alternative pathogens 1
Hyperbilirubinemia Investigation
Context of the Elevated Bilirubin
The total bilirubin of 79 µmol/L is significantly elevated for a 7-year-old. Normal reference ranges for children >1 month to 18 years show upper limits of only 15-17 µmol/L 3. This represents approximately 5-fold elevation.
Critical Next Steps for Bilirubin Workup
Immediately obtain:
- Direct (conjugated) vs indirect (unconjugated) bilirubin fractionation - This is the single most important test
- Liver transaminases (AST, ALT), alkaline phosphatase, GGT
- Albumin and coagulation studies (PT/INR)
Differential Diagnosis Framework
If conjugated hyperbilirubinemia (direct >20% of total):
- Sepsis-associated cholestasis (most likely given pneumonia context) 4
- Hepatobiliary pathology requiring urgent evaluation
- Drug-induced liver injury
If unconjugated hyperbilirubinemia:
- Hemolysis (check CBC, reticulocyte count, peripheral smear)
- Gilbert syndrome (less likely with this degree of elevation)
Infection-Related Hyperbilirubinemia
Bacterial pneumonia can cause hyperbilirubinemia through disturbance in bilirubin metabolism without hepatocyte necrosis, particularly in severe infections 4. If liver enzymes are normal or minimally elevated with conjugated hyperbilirubinemia, this suggests infection-related cholestasis that should improve with successful pneumonia treatment.
Common Pitfalls to Avoid
- Do not delay antibiotics while investigating the bilirubin - treat the pneumonia immediately
- Do not assume the bilirubin is solely infection-related without proper fractionation and liver function testing
- Do not obtain routine chest X-rays unless clinically indicated for complications, as they increase antibiotic use without improving outcomes 5
- Do not routinely order viral testing - it does not change management in typical cases 5
Discharge Criteria (When Applicable)
Patient can be discharged when:
- Clinical improvement for 12-24 hours (activity, appetite, decreased fever) 1
- Oxygen saturation >90% on room air for 12-24 hours 1
- Tolerating oral antibiotics 1
- No increased work of breathing or sustained tachypnea 1
Specific Monitoring Plan
- Day 0-3: Monitor clinical response to antibiotics, obtain bilirubin fractionation and liver function tests
- If bilirubin improves with pneumonia treatment: Likely infection-related, continue antibiotics
- If bilirubin worsens or liver dysfunction develops: Consider hepatology consultation and investigate alternative causes
- If no pneumonia improvement by 48-72 hours: Reassess per algorithm above 1